China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)

SHE:300294 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,300	1,961	1,532	1,584	753.89
Trading Asset Securities	2,199	3,362	3,194	2,700	-
Cash & Short-Term Investments	3,499	5,324	4,726	4,284	753.89
Cash Growth	-34.28%	12.66%	10.31%	468.21%	32.55%
Accounts Receivable	509.38	275.92	567.02	588.08	681.01
Other Receivables	39.81	264.4	100.62	67.9	53.21
Receivables	549.19	540.32	667.64	655.98	734.22
Inventory	995.43	556.94	666.96	676.84	689.46
Other Current Assets	14.75	6.43	13.25	29.4	750.08
Total Current Assets	5,058	6,428	6,073	5,646	2,928
Property, Plant & Equipment	1,170	676.62	722.81	771.33	809.52
Long-Term Investments	81.09	100.39	117.09	144.96	311.66
Goodwill	728	72.61	663.84	663.84	663.84
Other Intangible Assets	773.28	269.31	312.17	169.47	198.6
Long-Term Deferred Tax Assets	73.54	47.34	44.99	27.44	20.57
Long-Term Deferred Charges	145.9	88.15	82.64	161.62	166.41
Other Long-Term Assets	370.79	146.83	16.24	37.2	60.27
Total Assets	8,401	7,829	8,033	7,622	5,159
Accounts Payable	357.62	126.35	303.46	277.53	285.88
Accrued Expenses	318.03	274.14	290.9	261.19	83.94
Short-Term Debt	-	-	-	-	220.2
Current Portion of Long-Term Debt	-	0.03	22.18	0.08	55.2
Current Portion of Leases	5.33	0.87	2.81	2.06	-
Current Income Taxes Payable	12.44	8.58	27.09	41.45	20.54
Current Unearned Revenue	4.08	12.21	20.58	12.97	14.51
Other Current Liabilities	52.88	34.26	38.33	35.66	191.66
Total Current Liabilities	750.38	456.45	705.34	630.94	871.93
Long-Term Debt	-	22.15	-	22.15	55
Long-Term Leases	7.17	1.4	10.37	11.3	-
Long-Term Unearned Revenue	19.51	23.52	27.09	30.98	32.44
Long-Term Deferred Tax Liabilities	136.32	4.56	5.56	5.94	6.71
Total Liabilities	913.38	508.07	748.35	701.3	966.08
Common Stock	504.25	504.25	504.25	511.63	433.32
Additional Paid-In Capital	4,063	4,063	4,065	4,258	1,947
Retained Earnings	2,918	2,753	2,616	2,259	1,928
Treasury Stock	-	-	-	-199.96	-199.96
Comprehensive Income & Other	2.36	-	-	-	-
Total Common Equity	7,487	7,320	7,186	6,829	4,108
Minority Interest	0.61	1.07	99.19	91.4	84.55
Shareholders' Equity	7,488	7,321	7,285	6,920	4,192
Total Liabilities & Equity	8,401	7,829	8,033	7,622	5,159
Total Debt	12.51	24.45	35.36	35.58	330.39
Net Cash (Debt)	3,486	5,299	4,690	4,248	423.5
Net Cash Growth	-34.21%	12.99%	10.41%	903.09%	-
Net Cash Per Share	6.94	10.49	9.33	9.74	0.99
Filing Date Shares Outstanding	504.25	504.25	504.25	504.25	425.94
Total Common Shares Outstanding	504.25	504.25	504.25	504.25	425.94
Working Capital	4,308	5,971	5,368	5,015	2,056
Book Value Per Share	14.85	14.52	14.25	13.54	9.64
Tangible Book Value	5,986	6,978	6,210	5,996	3,245
Tangible Book Value Per Share	11.87	13.84	12.31	11.89	7.62
Buildings	741.4	527.95	518.01	536.62	506.23
Machinery	839.25	625.83	671.97	665.73	632.37
Construction In Progress	321	39.94	69.34	40.86	80.9

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.